The Walking Wounded: Emerging Treatments for PTSD

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Psychiatry Reports

• Publication date

  2018-09-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11920-018-0941-8PMID 30218438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DBS in Treatment of Post-Traumatic Stress Disorder

  2018cited by this paper
• Trial of Prazosin for Post‐Traumatic Stress Disorder in Military Veterans

  2018cited by this paper
• Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder

  2018cited by this paper
• An Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future Research on Doxazosin.

  2018cited by this paper
• Long-term efficacy of psychotherapy for posttraumatic stress disorder: A meta-analysis of randomized controlled trials.

  2018cited by this paper
• A randomized controlled trial of ganaxolone in posttraumatic stress disorder

  2017cited by this paper
• A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

  2017cited by this paper
• Novel pharmacological treatment strategies for posttraumatic stress disorder

  2017cited by this paper
• Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.

  2017cited by this paper
• MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics".

  2017cited by this paper
• Neuropeptide Y, resilience, and PTSD therapeutics.

  2017cited by this paper
• Neuroactive steroids and PTSD treatment.

  2017cited by this paper
• Review of Virtual Reality Treatment in Psychiatry: Evidence Versus Current Diffusion and Use

  2017cited by this paper
• Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic

  2017cited by this paper
• Use of Integrative Medicine in the United States Military Health System

  2017cited by this paper
• HORIZONS – a new study to explore the short, medium and long term consequences of a cancer diagnosis and cancer treatment

  2017cited by this paper
• It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group.

  2017cited by this paper
• Cannabinoids as therapeutic for PTSD.

  2017cited by this paper
• A Randomized, Head-to-Head Study of Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder

  2017cited by this paper
• Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial

  2017cited by this paper
• Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: A randomized clinical trial.

  2017cited by this paper
• Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.

  2017cited by this paper
• Meditation and yoga for posttraumatic stress disorder: A meta-analytic review of randomized controlled trials.

  2017cited by this paper
• Poster Presentations

  2017cited by this paper
• Intranasal oxytocin increases neural responses to social reward in post-traumatic stress disorder

  2016cited by this paper
• Ketamine for treatment-resistant depression: recent developments and clinical applications

  2016cited by this paper
• Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin.

  2016cited by this paper
• A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.

  2016cited by this paper
• PTSD: from neurobiology to pharmacological treatments

  2016cited by this paper
• Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.

  2016cited by this paper
• Intranasal Oxytocin Normalizes Amygdala Functional Connectivity in Posttraumatic Stress Disorder

  2016cited by this paper
• Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future.

  2016cited by this paper
• Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

  2014cited by this paper
• Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

  2014cited by this paper
• World Health Organization Guidelines for Management of Acute Stress, PTSD, and Bereavement: Key Challenges on the Road Ahead

  2014cited by this paper
• Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

  2014cited by this paper
• Posttraumatic stress disorder in veterans and military personnel: epidemiology, screening, and case recognition.

  2012cited by this paper
• Evidence Brief: Effectiveness of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder (PTSD)

  2011cited by this paper
• Correlates of utilization of PTSD specialty treatment among recently diagnosed veterans at the VA.

  2011cited by this paper
• Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq.

  2010cited by this paper
• Quantitative measurements of released amines from individual exocytosis events

  1997cited by this paper

• Ketamine for mental health - A naturalistic inventory of prescribing practices, safety, and adverse effects

  2025cites this paper
• Effects of physical activity on patients with posttraumatic stress disorder: A systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Impact and efficiency of treatment across two PTSD clinical trials comparing in-person and telehealth service delivery formats.

  2023cites this paper
• Study protocol: A multimethod psychophysiological randomized controlled trial of a couple therapy for post-traumatic stress disorder.

  2023cites this paper
• NMDA receptors: Biological properties and their roles in neuropsychiatric disorders

  2022influential citation
• Exploring the Transmucosal Permeability of Cyclobenzaprine: A Comparative Preformulation by Standardized and Controlled Ex Vivo and In Vitro Permeation Studies.

  2021cites this paper
• MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t

  2020cites this paper
• Clinical research on behavioral activation as treatment for post‐traumatic stress disorder: A brief review and meta‐analysis

  2020cites this paper
• Predator-induced fear causes PTSD-like changes in the brains and behaviour of wild animals

  2019cites this paper